Company intelligence
NeuroDiscovery AI
Molecule to Market and Beyond
Biotechnology Research
Atlanta, US
79 employees
Founded 2023
2 public signals
About NeuroDiscovery AI
Neurology-specialized AI platform that leverages its proprietary multi-modal LLM (NeuroLLM™)—trained on over 6+ million patient records—to do the following: - accelerate clinical trials, - deliver real-world data, - generate real-world evidence While driving clinical excellence through strategic partnerships with the largest and most influential Neurology Practice Groups in the U.S.
Verified activity
Signals from NeuroDiscovery AI
2 published signals
Research & Knowledge
NeuroDiscovery AI is breaking down the 5 Cs of Data Quality for Alzheimer's and MCI patients in real-world EHR data over the next few weeks.
Reported by NeuroDiscovery AI
Presence & Recognition
NeuroDiscovery AI is presenting new findings on early utilization patterns of Donanemab in early Alzheimer's Disease at the ISPE 42nd Annual Meeting in Milan.
Reported by NeuroDiscovery AI